We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Miracle Mineral Solution (MMS) and sodium chlorite solutions and their danger to health.
Guidance to help you assess if artificial intelligence (AI) is the right technology for your challenge.
Teva UK Limited is reporting a labelling error on the carton for Ponlimsi (Denosumab) 60mg Solution for injection in Pre-filled Syringe. The carton states “For application to the skin” when the product is licensed for subcutaneous use.
Templates of the Supplier Solution documentation to be used under the 2016 State aid decision
Engage with MOD on SKYNET Integrated Enterprise Solution, a transformation project developing and assessing options for the future delivery model for the SKYNET programme.
Guidance notes for applicants on the National Security Vetting Solution.
Change to the information provided on adverse events in the Summary of Product Characteristics (SPC).
Do not include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).